0001209191-23-013280.txt : 20230227
0001209191-23-013280.hdr.sgml : 20230227
20230227171616
ACCESSION NUMBER: 0001209191-23-013280
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230223
FILED AS OF DATE: 20230227
DATE AS OF CHANGE: 20230227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gao Hanlin
CENTRAL INDEX KEY: 0001684532
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37894
FILM NUMBER: 23676598
MAIL ADDRESS:
STREET 1: 2325 CLUB VISTA DRIVE
CITY: GLENDORA
STATE: CA
ZIP: 91741
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fulgent Genetics, Inc.
CENTRAL INDEX KEY: 0001674930
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 812621304
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4978 SANTA ANITA AVENUE, SUITE 205
CITY: TEMPLE CITY
STATE: CA
ZIP: 91780
BUSINESS PHONE: 626-350-0537
MAIL ADDRESS:
STREET 1: 4978 SANTA ANITA AVENUE, SUITE 205
CITY: TEMPLE CITY
STATE: CA
ZIP: 91780
FORMER COMPANY:
FORMER CONFORMED NAME: Fulgent Diagnostics, Inc.
DATE OF NAME CHANGE: 20160517
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-23
0
0001674930
Fulgent Genetics, Inc.
FLGT
0001684532
Gao Hanlin
C/O FULGENT GENETICS, INC.
4978 SANTA ANITA AVE, STE 205
TEMPLE CITY
CA
91780
0
1
0
0
Chief Scientific Officer
Common Stock
2023-02-23
4
A
0
2142
0.00
A
908254
D
Common Stock
2023-02-23
4
A
0
12156
0.00
A
920410
D
Common Stock
2023-02-23
4
F
0
794
31.65
D
919616
D
Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 28, 2022.
Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after February 23, 2023, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date.
The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 28, 2022.
/s/ Paul Kim as Attorney-in-Fact
2023-02-27